Geopolitical Squeeze on India's Generic Drug Production Reveals Fragile Manufacturing Base
Regional conflict is exposing a critical weakness in global pharmaceutical manufacturing: India's generic drug producers are getting squeezed from multiple directions simultaneously, raising questions about whether the world's pharmacy can maintain reliable production. The pressure comes not from a single shock, but from compounding stresses on margins and operations.
Bottom Line
India's generic drug manufacturers are facing simultaneous pressure from supply chain disruptions, higher operational costs, and raw material dependencies. The result is margin squeeze that could translate into higher prices or supply constraints. This isn't a crisis yet, but it demonstrates how quickly geopolitical instability can stress industries that depend on predictable international operations and thin profit margins.